ClinMark Therapeutics
About
Digital technologies
Health
Additional Information
Business Project Description
Poor patient stratification and limited predictive biomarkers reduce treatment effectiveness. ClinMark Therapeutics is developing an AI-driven platform that predicts therapeutic response by matching patient profiles with real-world multimodal response signatures. Target customers include pharma, CROs, and research centers. Funding and coaching will support MVP development, dataset harmonization, AI infrastructure, and key hires.
Product/Technology Development Stage
Proof of conceptOrganization description
ClinMark Therapeutics is an early-stage precision medicine startup founded by a translational oncology researcher and supported by clinical and scientific collaborators. The team combines expertise in oncology, hepatology, pathology, biomarker discovery, clinical trials, and biostatistics, with access to longitudinal patient cohorts for platform development and validation. Its mission is to advance precision medicine through therapeutic response prediction.
Team size
3-5Team Background
IPR Status
If other, describe it
None
If other, describe it
None
Annual turnover (€)
no turnoverWould you like to apply for the pitching session and EEN award? (only for participants based in Lombardy)
YesEstablishment year
2026
Type of funding raised
I participated in the Start Cup initiative of Lombardy Region
YesI received the Seal of Excellence for an EIC Accelerator project proposal
NoRepresentatives
ClinMark Therapeutics